These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 7911164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, Bryson YJ.
    JAMA; 1996 Feb 28; 275(8):599-605. PubMed ID: 8594240
    [Abstract] [Full Text] [Related]

  • 3. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL.
    N Engl J Med; 1994 Nov 03; 331(18):1173-80. PubMed ID: 7935654
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA, Whitehouse J, Moye J, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ.
    N Engl J Med; 1999 Aug 05; 341(6):385-93. PubMed ID: 10432323
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort.
    Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Bénifla JL, Delfraissy JF, Blanche S, Mayaux MJ.
    JAMA; 1998 Jul 01; 280(1):55-60. PubMed ID: 9660364
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE, Kumwenda NI, Hoover DR, Fiscus SA, Kafulafula G, Nkhoma C, Nour S, Chen S, Liomba G, Miotti PG, Broadhead RL.
    JAMA; 2004 Jul 14; 292(2):202-9. PubMed ID: 15249569
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    Kesho Bora Study Group, de Vincenzi I.
    Lancet Infect Dis; 2011 Mar 14; 11(3):171-80. PubMed ID: 21237718
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Update on vertical HIV transmission.
    Groginsky E, Bowdler N, Yankowitz J.
    J Reprod Med; 1998 Aug 14; 43(8):637-46. PubMed ID: 9749412
    [Abstract] [Full Text] [Related]

  • 14. Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center.
    Wiznia AA, Crane M, Lambert G, Sansary J, Harris A, Solomon L.
    JAMA; 1996 May 15; 275(19):1504-6. PubMed ID: 8622226
    [Abstract] [Full Text] [Related]

  • 15. Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women.
    Jackson JB, Kataaha P, Hom DL, Mmiro F, Guay L, Ndugwa C, Marum L, Piwowar E, Brewer K, Toedter G.
    AIDS; 1993 Nov 15; 7(11):1475-9. PubMed ID: 8280414
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
    Abrams EJ, Matheson PB, Thomas PA, Thea DM, Krasinski K, Lambert G, Shaffer N, Bamji M, Hutson D, Grimm K.
    Pediatrics; 1995 Sep 15; 96(3 Pt 1):451-8. PubMed ID: 7651777
    [Abstract] [Full Text] [Related]

  • 18. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M, Mashi Study Team.
    JAMA; 2006 Aug 16; 296(7):794-805. PubMed ID: 16905785
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France.
    Mayaux MJ, Teglas JP, Mandelbrot L, Berrebi A, Gallais H, Matheron S, Ciraru-Vigneron N, Parnet-Mathieu F, Bongain A, Rouzioux C, Delfraissy JF, Blanche S.
    J Pediatr; 1997 Dec 16; 131(6):857-62. PubMed ID: 9427890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.